Cryptotanshinone Promotes Brown Fat Activity by AMPK Activation to Inhibit Obesity

Overview

Journal Nutr Res Pract

Specialty Nutritional Sciences

Date 2024 Aug 7

PMID 39109201

Authors

Jie Ni

Aili Ye

Liya Gong

Xiafei Zhao

Sisi Fu

Jieya Guo

Affiliations

Soon will be listed here.

Abstract

Background/objectives: Activating brown adipose tissue (BAT) and browning of white adipose tissue (WAT) can protect against obesity and obesity-related metabolic conditions. Cryptotanshinone (CT) regulates lipid metabolism and significantly ameliorates insulin resistance. Adenosine-5'-monophosphate (AMP)-activated protein kinase (AMPK), a receptor for cellular energy metabolism, is believed to regulate brown fat activity in humans.

Materials/methods: The study included high-fat-fed obese mice administered orally 200/400 mg/kg/d CT. They were evaluated through weight measurement, the intraperitoneal glucose tolerance test (IPGTT), intraperitoneal insulin tolerance test (IPITT), cold stimulation test, serum lipid (total cholesterol, triglycerides, and low-density lipoprotein) measurement, hematoxylin and eosin staining, and immunohistochemistry. Furthermore, the study investigated primary adipose mesenchymal stem cells (MSCs) with incubation of CT and AMPK agonists (acadesine)/inhibitor (Compound C). Cells were evaluated using Oil Red O staining, Alizarin red staining, flow cytometry, and immunofluorescence staining to identify and observe the osteogenic versus adipogenic differentiation. Quantitative real-time polymerase chain reaction and the Western blot were used to observe related gene expression.

Results: In the diet-induced obesity mouse model mice CT suppressed body weight, food intake, glucose levels in the IPGTT and IPTT, serum lipids, the volume of adipose tissue, and increased thermogenesis, uncoupling protein 1, and the AMPK pathway expression. In the study, CT prevented the formation of lipid droplets from MSCs while activating brown genes and the AMPK pathway. AMPK activator enhanced CT's effects, while the AMPK inhibitor reversed the effects of CT.

Conclusion: CT promotes adipose tissue browning to increase body thermogenesis and reduce obesity by activating the AMPK pathway. This study provides an experimental foundation for the use of CT in obesity treatment.

References

Wang Q, Li H, Tajima K, Verkerke A, Taxin Z, Hou Z . Post-translational control of beige fat biogenesis by PRDM16 stabilization. Nature. 2022; 609(7925):151-158. PMC: 9433319. DOI: 10.1038/s41586-022-05067-4. View

Chouchani E, Kazak L, Spiegelman B . New Advances in Adaptive Thermogenesis: UCP1 and Beyond. Cell Metab. 2018; 29(1):27-37. DOI: 10.1016/j.cmet.2018.11.002. View

Wang X, Morris-Natschke S, Lee K . New developments in the chemistry and biology of the bioactive constituents of Tanshen. Med Res Rev. 2006; 27(1):133-48. DOI: 10.1002/med.20077. View

Imran K, Rahman N, Yoon D, Jeon M, Lee B, Kim Y . Cryptotanshinone promotes commitment to the brown adipocyte lineage and mitochondrial biogenesis in C3H10T1/2 mesenchymal stem cells via AMPK and p38-MAPK signaling. Biochim Biophys Acta Mol Cell Biol Lipids. 2017; 1862(10 Pt A):1110-1120. DOI: 10.1016/j.bbalip.2017.08.001. View

Hu M, Zhang D, Xu H, Zhang Y, Shi H, Huang X . Salidroside Activates the AMP-Activated Protein Kinase Pathway to Suppress Nonalcoholic Steatohepatitis in Mice. Hepatology. 2021; 74(6):3056-3073. DOI: 10.1002/hep.32066. View

Steinberg G, Grahame Hardie D . New insights into activation and function of the AMPK. Nat Rev Mol Cell Biol. 2022; 24(4):255-272. DOI: 10.1038/s41580-022-00547-x. View

Zhang S, Li J, Shi X, Tan X, Si Q . Naringenin activates beige adipocyte browning in high fat diet-fed C57BL/6 mice by shaping the gut microbiota. Food Funct. 2022; 13(19):9918-9930. DOI: 10.1039/d2fo01610a. View

Vandevijvere S, De Pauw R, Djojosoeparto S, Gorasso V, Guariguata L, Lovhaug A . Upstream Determinants of Overweight and Obesity in Europe. Curr Obes Rep. 2023; 12(4):417-428. DOI: 10.1007/s13679-023-00524-1. View

Terado T, Kim C, Ushio A, Minami K, Tambe Y, Kageyama S . Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS‑activated pancreatic cancer cells. Int J Oncol. 2022; 61(3). PMC: 9339489. DOI: 10.3892/ijo.2022.5398. View

10.

Tang H, Zeng Q, Tang T, Wei Y, Pu P . Kaempferide improves glycolipid metabolism disorder by activating PPARγ in high-fat-diet-fed mice. Life Sci. 2021; 270:119133. DOI: 10.1016/j.lfs.2021.119133. View

11.

Diniz T, de Lima Junior E, Teixeira A, Biondo L, da Rocha L, Cordeiro Valadao I . Aerobic training improves NAFLD markers and insulin resistance through AMPK-PPAR-α signaling in obese mice. Life Sci. 2020; 266:118868. DOI: 10.1016/j.lfs.2020.118868. View

12.

. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. 2024; 403(10431):1027-1050. PMC: 7615769. DOI: 10.1016/S0140-6736(23)02750-2. View

13.

Crichton P, Lee Y, Kunji E . The molecular features of uncoupling protein 1 support a conventional mitochondrial carrier-like mechanism. Biochimie. 2017; 134:35-50. PMC: 5395090. DOI: 10.1016/j.biochi.2016.12.016. View

14.

Zhang F, Ma T, Tong X, Liu Y, Cui P, Xu X . Electroacupuncture improves metabolic and ovarian function in a rat model of polycystic ovary syndrome by decreasing white adipose tissue, increasing brown adipose tissue, and modulating the gut microbiota. Acupunct Med. 2021; 40(4):347-359. DOI: 10.1177/09645284211056663. View

15.

Zhu Q, An Y, Scherer P . Mitochondrial regulation and white adipose tissue homeostasis. Trends Cell Biol. 2021; 32(4):351-364. PMC: 8918005. DOI: 10.1016/j.tcb.2021.10.008. View

16.

Reid T, Korner J . Medical and Surgical Treatment of Obesity. Med Clin North Am. 2022; 106(5):837-852. DOI: 10.1016/j.mcna.2022.03.002. View

17.

Ding X, Jian T, Li J, Lv H, Tong B, Li J . Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NFB Signaling Pathway and Restores Gut Microbiota in High-Fat-Diet-Fed Mice. Oxid Med Cell Longev. 2020; 2020:9734560. PMC: 7657699. DOI: 10.1155/2020/9734560. View

18.

Muller T, Bluher M, Tschop M, DiMarchi R . Anti-obesity drug discovery: advances and challenges. Nat Rev Drug Discov. 2021; 21(3):201-223. PMC: 8609996. DOI: 10.1038/s41573-021-00337-8. View

19.

Fink J, Seifert G, Bluher M, Fichtner-Feigl S, Marjanovic G . Obesity Surgery. Dtsch Arztebl Int. 2021; 119(5):70-80. PMC: 9059860. DOI: 10.3238/arztebl.m2021.0359. View

20.

Diamantis D, Karatzi K, Kantaras P, Liatis S, Iotova V, Bazdraska Y . Prevalence and Socioeconomic Correlates of Adult Obesity in Europe: The Feel4Diabetes Study. Int J Environ Res Public Health. 2022; 19(19). PMC: 9566241. DOI: 10.3390/ijerph191912572. View